CELG

Celgene (CELG)

Celgene Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CELG

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next >>

Date	Time	Source	Headline	Symbol	Company
06/15/2018	4:18PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/15/2018	4:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/15/2018	4:15PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/15/2018	4:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/14/2018	4:37PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/14/2018	4:01PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CELG	Celgene Corporation
06/13/2018	4:19PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
06/13/2018	12:13PM	Business Wire	ASCO 2018 – Ergebnisse der Phase-III-Studie OPTIMISMM: Verbesserung des progressionsfreien Überlebens durch Triplettkombin...	NASDAQ:CELG	Celgene Corporation
06/11/2018	4:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/07/2018	2:44PM	Business Wire	Presentati Ad ASCO 2018 I Risultati Dello Studio Di Fase III RELEVANCE™ Che Compara Lenalidomide Più Rituximab (R2) Rispet...	NASDAQ:CELG	Celgene Corporation
06/05/2018	4:17PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/05/2018	4:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
06/03/2018	12:09PM	Business Wire	Celgene Announces Updated Safety & Efficacy Data from the TRANSCEND Trial of liso-cel (JCAR017) in Patients with Relapsed or ...	NASDAQ:CELG	Celgene Corporation
06/03/2018	10:45AM	Business Wire	Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R2) Versus Rituximab Plus Chemotherapy in Patients wi...	NASDAQ:CELG	Celgene Corporation
06/01/2018	5:57PM	Business Wire	Updated Results of Ongoing Multicenter Phase I Study of bb2121 anti-BCMA CAR T Cell Therapy Continue to Demonstrate Deep & Du...	NASDAQ:CELG	Celgene Corporation
06/01/2018	4:00PM	Business Wire	Results of Phase III OPTIMISMM Study Presented at ASCO 2018 Showed the PVd Triplet Improved PFS in Early Lines of Relapsed or...	NASDAQ:CELG	Celgene Corporation
06/01/2018	6:10AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
05/31/2018	4:30PM	Business Wire	Celgene Corp. Announces Hiring of David V. Elkins as Executive Vice President, Chief Financial Officer & Appointment of Peter...	NASDAQ:CELG	Celgene Corporation
05/31/2018	7:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
05/28/2018	10:50PM	Business Wire	CELGENE 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,00...	NASDAQ:CELG	Celgene Corporation
05/24/2018	7:55AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
05/24/2018	7:30AM	Business Wire	Celgene Corp. Announces Additional $3 Billion Share Repurchase Authorization & Plans to Execute a $2 Billion Accelerated Shar...	NASDAQ:CELG	Celgene Corporation
05/23/2018	4:58PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CELG	Celgene Corporation
05/22/2018	7:30AM	Business Wire	Celgene to Present New and Updated Data across a Range of Blood Diseases at EHA 2018	NASDAQ:CELG	Celgene Corporation
05/21/2018	4:45PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
05/18/2018	5:29PM	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:CELG	Celgene Corporation
05/18/2018	4:44PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CELG	Celgene Corporation
05/17/2018	4:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
05/17/2018	4:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
05/17/2018	4:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation